Publications searcher The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points. Fulltext search Alphabetic A-Z Alphabetic Z-A Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. PMID: 19515553 Journal: EUROPEAN JOURNAL OF CANCER Year: 2009 Reference: Eur J Cancer. 2009 Sep;45(13):2324-32. Epub 2009 Jun 8. Impact factor: 4.475 Publication type: Paper in international publication Authors: Vergote, I, Finkler, N, del Campo, J, Lohr, A, Hunter, J, Matei, D, Kavanagh, J, Vermorken, J B, Meng, L, Jones, M et al. DOI: 10.1016/j.ejca.2009.05.016 Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer. PMID: 19515553 Journal: EUROPEAN JOURNAL OF CANCER Year: 2009 Reference: Eur J Cancer. 2009 Sep;45(13):2324-32. Epub 2009 Jun 8. Impact factor: Publication type: Paper in international publication Authors: Brown, G; del Campo, J; Finkler, N; Hunter, J; Jones, M; Kavanagh, J; Kaye, S; Lohr, A; Matei, D; Meng, L et al. DOI: 10.1016/j.ejca.2009.05.016 Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. PMID: 19786654 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Dec 1;27(34):5800-7. Epub 2009 Sep 28. Impact factor: 17.157 Publication type: Paper in international publication Authors: Roth, Bruce, Tolcher, Anthony W, Sarantopoulos, John, Patnaik, Amita, Papadopoulos, Kyriakos, Lin, Chia-Chi, Rodon, Jordi, Murphy, Barbara, Kaiser, Brianne, Zhu, Min et al. DOI: 10.1200/JCO.2009.23.6745 Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1. PMID: 19786654 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Dec 1;27(34):5800-7. Epub 2009 Sep 28. Impact factor: Publication type: Paper in international publication Authors: Deng, Hongjie; Friberg, Greg; Gorski, Kevin S; Kaiser, Brianne; Lin, Chia-Chi; McCaffery, Ian; Murphy, Barbara; Papadopoulos, Kyriakos; Patnaik, Amita; Puzanov, Igor et al. DOI: 10.1200/JCO.2009.23.6745 Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors. PMID: 18795291 Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY Year: 2009 Reference: Cancer Chemother Pharmacol. 2009 May;63(6):1065-71. Impact factor: 2.74 Publication type: Paper in international publication Authors: Dancey, Janet E, Chen, Helen, Tolcher, Anthony W, Takimoto, Chris H, O'Rourke, Pat, Mays, Theresa, Lin, Chia-Chi, Calvo, Emiliano, Papadopoulos, Kyriakos P, Patnaik, Amita et al. DOI: 10.1007/s00280-008-0811-x Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors. PMID: 18795291 Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY Year: 2009 Reference: Cancer Chemother Pharmacol. 2009 May;63(6):1065-71. Impact factor: Publication type: Paper in international publication Authors: Calvo, Emiliano; Chen, Helen; Dancey, Janet E; Lin, Chia-Chi; Mays, Theresa; Mita, Alain C; Mita, Monica M; O'Rourke, Pat; Papadopoulos, Kyriakos P; Patnaik, Amita et al. DOI: 10.1007/s00280-008-0811-x Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer. PMID: 19075286 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Feb 1;27(4):526-34. Impact factor: 17.157 Publication type: Paper in international publication Authors: Ciruelos, Eva, Egyhazi, Suzanne, Xu, Li-An, Zerba, Kim E, Lee, Hyerim, Clark, Edwin, Galbraith, Susan, Verrill, Mark, Ludwig, Heinz, Makhson, Anatoly et al. DOI: 10.1200/JCO.2007.14.2646 Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer. PMID: 19075286 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Feb 1;27(4):526-34. Impact factor: Publication type: Paper in international publication Authors: Baselga, Jose; Ciruelos, Eva; Clark, Edwin; Egyhazi, Suzanne; Galbraith, Susan; Kubista, Ernst; Lee, Hyerim; Llombart-Cussac, Antoni; Ludwig, Heinz; Makhson, Anatoly et al. DOI: 10.1200/JCO.2007.14.2646 Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. PMID: 19380449 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Jun 1;27(16):2630-7. Impact factor: 17.157 Publication type: Paper in international publication Authors: Semiglazov, Vladimir, van Dam, Peter, Manikhas, Alexey, Bellet, Meritxell, Mayordomo, Jose, Campone, Mario, Kubista, Ernst, Greil, Richard, Bianchi, Giulia, Steinseifer, Jutta et al. DOI: 10.1200/JCO.2008.18.8391 Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer. PMID: 19380449 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Jun 1;27(16):2630-7. Impact factor: Publication type: Paper in international publication Authors: Baselga, Jose; Bellet, Meritxell; Bianchi, Giulia; Campone, Mario; Dixon, J Michael; Gardner, Humphrey; Greil, Richard; Jonat, Walter; Kubista, Ernst; Lane, Heidi A et al. DOI: 10.1200/JCO.2008.18.8391 Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma. PMID: 19370171 Journal: Marine Drugs Year: 2009 Reference: Mar Drugs. 2009;7(1):57-70. Impact factor: 1.2 Publication type: Paper in international publication Authors: Rivera, Fernando, Schoffski, Patrick, Guillem, Vincente, Garcia, Margarita, Lopez-Martin, Jose Antonio, Pollard, Patricia, Dumez, Herlinde, del Muro, Xavier Garcia, Paz-Ares, Luis, Cullell, Martin et al. DOI: 10.3390/md7010057 Phase II randomized study of Plitidepsin (Aplidin), alone or in association with L-carnitine, in patients with unresectable advanced renal cell carcinoma. PMID: 19370171 Journal: Marine Drugs Year: 2009 Reference: Mar Drugs. 2009;7(1):57-70. Impact factor: Publication type: Paper in international publication Authors: Cullell, Martin; del Muro, Xavier Garcia; Dumez, Herlinde; Garcia, Margarita; Guillem, Vincente; Lopez-Martin, Jose Antonio; Paz-Ares, Luis; Pollard, Patricia; Rivera, Fernando; Schoffski, Patrick et al. DOI: 10.3390/md7010057 Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. PMID: 19556318 Journal: ANNALS OF ONCOLOGY Year: 2009 Reference: Ann Oncol. 2009 Nov;20(11):1794-802. Epub 2009 Jun 25. Impact factor: 4.935 Publication type: Paper in international publication Authors: Cikowska-Wozniak, E, Del Campo, J M, Roszak, A, Bidzinski, M, Ciuleanu, T E, Hogberg, T, Wojtukiewicz, M Z, Poveda, A, Boman, K, Westermann, A M et al. DOI: 10.1093/annonc/mdp198 Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. PMID: 19556318 Journal: ANNALS OF ONCOLOGY Year: 2009 Reference: Ann Oncol. 2009 Nov;20(11):1794-802. Epub 2009 Jun 25. Impact factor: Publication type: Paper in international publication Authors: Alfaro, V; Alonso-Carrion, L; Balana, C; Bidzinski, M; Boman, K; Brugger, W; Casado, A; Cikowska-Wozniak, E; Ciuleanu, T E; Curescu, S et al. DOI: 10.1093/annonc/mdp198 Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. PMID: 19540072 Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Year: 2009 Reference: Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1430-6. Impact factor: 4.639 Publication type: Paper in international publication Authors: Rivera, Fernando, Galan, Maica, Tabernero, Josep, Cervantes, Andres, Vega-Villegas, M Eugenia, Gallego, Javier, Laquente, Berta, Rodriguez, Edith, Carrato, Alfredo, Escudero, Pilar et al. DOI: 10.1016/j.ijrobp.2008.12.087 Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. PMID: 19540072 Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Year: 2009 Reference: Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1430-6. Impact factor: Publication type: Paper in international publication Authors: Alonso-Orduna, Vicente; Anton, Antonio; Aranda, Enrique; Cardenal, Adelaida; Carrato, Alfredo; Cervantes, Andres; Escudero, Pilar; Galan, Maica; Gallego, Javier; Giralt, Jordi et al. DOI: 10.1016/j.ijrobp.2008.12.087 Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. PMID: 19332727 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 May 20;27(15):2474-81. Impact factor: 17.157 Publication type: Paper in international publication Authors: Eiermann, Wolfgang, Gianni, Luca, Baselga, Jose, Lluch, Ana, Zambetti, Milvia, Sabadell, Dolores, Raab, Gunther, Cussac, Antonio Llombart, Bozhok, Alla, Martinez-Agullo, Angel et al. DOI: 10.1200/JCO.2008.19.2567 Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. PMID: 19332727 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 May 20;27(15):2474-81. Impact factor: Publication type: Paper in international publication Authors: Baselga, Jose; Bonadonna, Gianni; Bozhok, Alla; Byakhov, Mikhail; Cussac, Antonio Llombart; Eiermann, Wolfgang; Gianni, Luca; Greco, Marco; Lluch, Ana; Lopez, Juan Jose Lopez et al. DOI: 10.1200/JCO.2008.19.2567 Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. PMID: 19687335 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Sep 20;27(27):4454-61. Epub 2009 Aug 17. Impact factor: 17.157 Publication type: Paper in international publication Authors: Bellmunt, Joaquim, Theodore, Christine, Demkov, Tomasz, Komyakov, Boris, Sengelov, Lisa, Daugaard, Gedske, Caty, Armelle, Carles, Joan, Jagiello-Gruszfeld, Agnieszka, Karyakin, Oleg et al. DOI: 10.1200/JCO.2008.20.5534 Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract. PMID: 19687335 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2009 Reference: J Clin Oncol. 2009 Sep 20;27(27):4454-61. Epub 2009 Aug 17. Impact factor: Publication type: Paper in international publication Authors: Bellmunt, Joaquim; Carles, Joan; Caty, Armelle; Culine, Stephane; Daugaard, Gedske; Delgado, Francois-Michel; Demkov, Tomasz; Hurteloup, Patrick; Jagiello-Gruszfeld, Agnieszka; Karyakin, Oleg et al. DOI: 10.1200/JCO.2008.20.5534 [Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods] PMID: 19186292 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Jan;45(1):4-11. Epub 2009 Jan 3. Impact factor: 1.624 Publication type: Paper in national publication Authors: Lopez, Lorena, Pare, Carles, Gea, Joaquim, Balcells, Eva, Orozco-Levi, Mauricio, Gayete, Angel, Casan, Pere, Guel, Rosa, Gimenez, Ana, Belda, Jose et al. DOI: 10.1016/j.arbres.2008.03.001 [Phenotypic characterization and course of chronic obstructive pulmonary disease in the PAC-COPD Study: design and methods] PMID: 19186292 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Jan;45(1):4-11. Epub 2009 Jan 3. Impact factor: Publication type: Paper in national publication Authors: Agusti, Alvar; Anto, J M; Anto, Josep M; Balcells, Eva; Barbera, Joan A; Belda, Jose; Benet, Marta; Casan, Pere; de Batlle, Jordi; Escarrabill, Joan et al. DOI: 10.1016/j.arbres.2008.03.001 [Phenotypic heterogeneity of chronic obstructive pulmonary disease] PMID: 19246148 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Mar;45(3):129-38. Impact factor: 1.624 Publication type: Review in national publication Authors: Anto, Josep M, Sauleda, Jaume, Garcia-Aymerich, Judith, Agusti, Alvar, Belda, Jose, Farrero, Eva, Ferrer, Antoni, Ferrer, Jaume, Galdiz, Juan B, Gea, Joaquim et al. DOI: 10.1016/j.arbres.2008.10.001 [Phenotypic heterogeneity of chronic obstructive pulmonary disease] PMID: 19246148 Journal: ARCHIVOS DE BRONCONEUMOLOGIA Year: 2009 Reference: Arch Bronconeumol. 2009 Mar;45(3):129-38. Impact factor: Publication type: Review in national publication Authors: Agusti, Alvar; Anto, Josep M; Barbera, Joan A; Belda, Jose; Farrero, Eva; Ferrer, Antoni; Ferrer, Jaume; Galdiz, Juan B; Garcia-Aymerich, Judith; Gea, Joaquim et al. DOI: 10.1016/j.arbres.2008.10.001 Pagination First page « First Previous page ‹ Previous … Page 1712 Page 1713 Page 1714 Page 1715 Current page 1716 Page 1717 Page 1718 Page 1719 Page 1720 … Next page Next › Last page Last »
